This inventor holds 4 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Bayer Aktiengesellschaft, Bayer Intellectual Property Gmbh. Active years: 1997-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 12,268 
2 out of 721 
Years Active: 1997-2019
Title: The Innovations of Hans-Jürgen Hamann
Introduction
Hans-Jürgen Hamann is a notable inventor based in Dormagen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative solutions for drug formulations. With a total of two patents to his name, his work has had a meaningful impact on the industry.
Latest Patents
Hamann's latest patents include groundbreaking inventions in the pharmaceutical sector. One of his notable patents focuses on "Pharmaceuticals containing fluoroquinolones." This invention relates to the use of quaternary ammonium compounds to prevent the precipitation of fluoroquinolones from their solutions. It also emphasizes the creation of stable, tolerated pharmaceuticals that are particularly suitable for parenteral use, containing both a fluoroquinolone and a quaternary ammonium compound in dissolved form. Another significant patent is for "Preparations containing amorphous emodepside." This invention involves preparations that comprise amorphous emodepside in a polyvinylpyrrolidone matrix, along with pharmaceuticals that utilize these preparations for combating endoparasites in both animals and humans.
Career Highlights
Throughout his career, Hamann has worked with prominent companies such as Bayer Intellectual Property GmbH and Bayer Animal Health GmbH. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to various projects that enhance drug efficacy and safety.
Collaborations
Hamann has collaborated with several professionals in his field, including Venkata-Rangarao Kanikanti and Petra Lange. These collaborations have fostered a productive environment for innovation and have led to the successful development of his patented technologies.
Conclusion
Hans-Jürgen Hamann's contributions to the pharmaceutical industry through his patents demonstrate his commitment to advancing medical science. His innovative approaches to drug formulation continue to influence the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile